No Data
No Data
Hongbo Pharmaceuticals (301230.SZ): has repurchased 1.0647% of the shares.
On July 2nd, Gelunhui reported that as of July 1, 2024, the company has repurchased a total of 1,486,200 shares through a repurchase special securities account in a centralized bidding trading manner, accounting for 1.0647% of the company's total share capital of 139,586,605 shares. The highest fill price was 37.68 yuan/share, the lowest fill price was 21.75 yuan/share, and the total transaction amount was 41,060,995.62 yuan (excluding transaction fees).
Dingtai Haifu, a shareholder of Hongbo Pharmaceutical (301230.SZ), has cumulatively reduced its shareholding by 0.0115% and its shareholding has fallen below 5%.
Hongbo Pharmaceuticals (301230.SZ) announced that the company's shareholder, Dingtai Haifu Investment Management Co., Ltd. (referred to as "Ding...")
Hongbo Pharmaceutical (301230.SZ) plans to increase 3 shares for every 10 shares and distribute a cash dividend of 3.3 yuan per share, with ex-rights and ex-dividend on June 21.
According to the announcement of Hongbo Pharmaceutical (301230.SZ) on the Zhitongcaijing APP, the company plans to distribute equity to all shareholders in 2023 as follows: a cash dividend of 3.3 yuan RMB (including tax) per 10 shares, and a bonus issue of 3 shares per 10 shares from the capital reserve. The ex-dividend date is June 21, 2024.
Hongbo Pharmaceutical (301230.SZ): Cumulative expenditure of 31.99 million yuan to repurchase 1% of shares.
On June 6, Glonhu announced that Hongbo Pharmaceuticals (301230.SZ) has repurchased a total of 1,076,200 shares as of June 6, 2024, through a repurchase special securities account in centralized bidding trading method, accounting for 1.00% of the company's current total share capital of 107,622,666 shares. The highest fill price was 37.68 yuan per share, the lowest fill price was 26.82 yuan per share, and the total trade amount was 31,994,035.11 yuan (excluding transaction costs).
Hongbo Pharmaceutical (301230.SZ): has repurchased 0.61% of its shares accumulated
On June 4, Gelonhui News reported that Hongbo Pharmaceuticals (301230.SZ) announced that as of May 31, 2024, the company has cumulatively repurchased 656,600 shares through a repurchase special securities account through centralized bidding trading, accounting for 0.6101% of the company's current total share capital of 107,622,666 shares. The highest transaction price was 37.68 yuan/share, and the lowest transaction price was 26.82 yuan/share, with a total transaction amount of 18.73995 million yuan (excluding transaction fees).
Hongbo Pharmaceutical (301230.SZ): Dingtai Haifu's shareholding ratio fell below 5%
Gelonghui, May 24, 丨 Hongbo Pharmaceutical (301230.SZ) announced that the company recently received the “Simplified Equity Change Report” issued by Dingtai Haifu. On May 24, 2024, Dingtai Haifu reduced its holdings of the company's shares through centralized bidding, accounting for 0.0517% of the company's total share capital. After this equity change, the total number of shares held by Dingtai Haifu decreased to 5,381,066 shares. The shareholding ratio dropped to 4.9999%, no longer holding 5% or more of the company's shares.
No Data